Towards the Human Colorectal Cancer Microbiome by Marchesi, Julian R. et al.
Towards the Human Colorectal Cancer Microbiome
Julian R. Marchesi
1, Bas E. Dutilh
2,3, Neil Hall
4, Wilbert H. M. Peters
5, Rian Roelofs
6, Annemarie Boleij
6,
Harold Tjalsma
6*
1School of Biosciences, Cardiff University, Cardiff, United Kingdom, 2Centre for Molecular and Biomolecular Informatics, Nijmegen Centre for Molecular Life Sciences,
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 3Departments of Computer Science and Biology, San Diego State University, San Diego,
California, United States of America, 4Centre for Genomic Research, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom, 5Department of
Gastroenterology, Nijmegen Institute for Infection, Inflammation and Immunity (N4i) & Radboud University Centre for Oncology (RUCO) of the Radboud University
Nijmegen Medical Centre, Nijmegen, The Netherlands, 6Department of Laboratory Medicine, Nijmegen Institute for Infection, Inflammation and Immunity (N4i) &
Radboud University Centre for Oncology (RUCO) of the Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Abstract
Multiple factors drive the progression from healthy mucosa towards sporadic colorectal carcinomas and accumulating
evidence associates intestinal bacteria with disease initiation and progression. Therefore, the aim of this study was to
provide a first high-resolution map of colonic dysbiosis that is associated with human colorectal cancer (CRC). To this
purpose, the microbiomes colonizing colon tumor tissue and adjacent non-malignant mucosa were compared by deep
rRNA sequencing. The results revealed striking differences in microbial colonization patterns between these two sites.
Although inter-individual colonization in CRC patients was variable, tumors consistently formed a niche for Coriobacteria
and other proposed probiotic bacterial species, while potentially pathogenic Enterobacteria were underrepresented in
tumor tissue. As the intestinal microbiota is generally stable during adult life, these findings suggest that CRC-associated
physiological and metabolic changes recruit tumor-foraging commensal-like bacteria. These microbes thus have an
apparent competitive advantage in the tumor microenvironment and thereby seem to replace pathogenic bacteria that
may be implicated in CRC etiology. This first glimpse of the CRC microbiome provides an important step towards full
understanding of the dynamic interplay between intestinal microbial ecology and sporadic CRC, which may provide
important leads towards novel microbiome-related diagnostic tools and therapeutic interventions.
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Introduction
The human intestinal tract contains about 10
14 bacteria,
comprising ,10
3 species, which are essential for digestion of
food, the control of intestinal epithelial homeostasis, intestinal
development and human health [1]. Conversely, a large body of
evidence supports a relationship between infective agents and
human cancers [2] and suggests that certain mucosa-associated
bacterial species play an important role in the pathogenesis of
colorectal cancer (CRC; [3,4,5]. Moreover, clinical associations
between bacterial infection and CRC have been described for
many decades, the most prominent of which concern infections
with Streptococcus bovis [6,7] and Clostridium septicum [8]. However,
the co-incidence of these infections with CRC is very low (,1%)
since such low-grade opportunistic pathogens can only become
clinically manifest in compromised patients. Correspondingly,
serological data have shown an increased exposure to S. bovis
antigens in early stage CRC patients without clinical signs of
bacterial infection [9]. Based on this, it has been suggested that
specific gut bacteria have a competitive advantage in the CRC
microenvironment, whereas opportunistic infections remain
repressed by the active immune system in the majority of
patients.
Recent publications have provided mechanistic evidence for the
involvement of gut bacteria in the development of CRC, which
comprises i), production of DNA damaging superoxide radicals, ii)
production of genotoxins, iii) T helper cell-dependent induction of
cell proliferation, iv) Toll-like receptor mediated induction of pro-
carcinogenic pathways [10–14]. Despite this vast body of
circumstantial evidence, however, no clinical data have thus far
been available to directly show distinct bacterial colonization
patterns in CRC patients. In fact, the molecular nature of the
complex intestinal community was largely unexplored prior to the
moment that Eckburg and coworkers [15] revealed the presence of
,400 bacterial species by sequencing prokaryotic ribosomal RNA
gene sequences from multiple colonic mucosal sites and feces of
healthy subjects. Further investigations revealed high intra-
individual variation of intestinal microbiomes in the human
population, whereas the microbial colonization of the mucosa
within adult individuals is relatively stable throughout the colon
[16–18]. Based on the latter observations we hypothesized that the
in-depth analysis of a relatively small number of paired on/off-
tumour tissue samples from CRC patients could disclose bacterial
species that might be implicated in CRC etiology. To achieve this
goal, we used deep pyrosequencing of bacterial rRNA to compare
CRC tumor microbiomes to that of adjacent non-malignant
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resolution image of the human CRC microbiome and showed that
CRC is associated with quite dramatic shifts in the adherent
intestinal microbiota.
Materials and Methods
Patient Material
Six patients (labeled A–F, Table 1) underwent resections for
primary colon adenocarcinomaat the Radboud University Nijmegen
Medical Centre. After resection, the colonic specimens were
extensively rinsed with sterile water after which the specimens were
examined by an oncological pathologist. Disease was staged
according to the Tumor-Node-Metastasis (TNM) classification [19].
From each colonic specimen, biopsies were taken from the tumor site
(‘‘on-tumor’’, Aon–Fon) and from adjacent non-malignant tissue (‘‘off-
tumor’’, Aoff–Foff) on the luminal side of the colonic wall (distance
about 5–10 cm). Tissue specimens were disrupted by mechanical
shearing after which total DNA was extracted using the AllPrep
DNA/RNA kit (Qiagen).Allsamples were stored at 280uCu n t i lu s e .
Ethics Statement
Research was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the by
the Medical Ethical Committee of the district Arnhem-Nijmegen
(The Netherlands); patients provided written informed consent for
the collection of samples and subsequent analysis when required.
Denaturing Gradient Gel Electrophoresis (DGGE) and
Ribosomal Intergenic Spacer Analysis (RISA)
Using total DNA from the 12 colonic biopsies as a template,
bacterial 16S rRNA genes were amplified by a nested approach
[20] using the primers pairs 27f/1492r [21] and L1401r/968f-GC
[22,23] in two subsequent PCR reactions (Table S1). DGGE was
performed on the resulting PCR mixture as described previously
[24]. It should be noted that visible bands (see Figure 1) represent
bacterial species that have an abundance of at least 1–10% of the
total community, whereas low abundant species will not result in a
detectable bands by this approach. To confirm DGGE data,
bacterial ribosomal intergenic spacer regions were amplified with
primers 1406f and 23Sr using the same DNA as template (Table
S1; [24]). RISA was performed as described previously [23].
FLX 454 titanium pyrosequencing
In the second step of the nested PCR approach, we amplified
the V1–V3 region of the bacterial 16S rRNA gene using primer
pairs tagged with 12 distinct Metagenome IDentification (MID)
tags (Table S1). 454 sequencing was performed at the University of
Liverpool’s Advanced Genomics Facility. Sequences are available
on request.
Read processing and community diversity
All partial 16S rRNA gene sequences were processed initially
using the Pyro-pipeline at the Ribosomal database project (RDP,
[25]; Release 10) to trim and remove primers from the partial
ribotags and to limit sequences to .400 bp and ,=500 bp,
sequences were processed using the pre.cluster command which
minimizes errors introduced by the pyrosequencing platform [26].
This step provided the datasets for analysis (Table S2) with the
read length histograms shown in Figure S2A. The data from all the
samples was processed using MOTHUR [27] to generate indices
of diversity, rarefaction curves (Figure S2B) and to undertake the
Libshuff analysis of sample similarity. MOTHUR was run using
the computational facilities of the Advanced Research Computing
@ Cardiff (ARCCA) Division, Cardiff University. Comparisons of
the libraries from an individual was performed using the RDP’s
Library compare tool. Analysis of the ribotags was also performed
using MEGAN [28] for which the input was the csv output from
the RDP’s classifier pipeline (using default settings and a
confidence level of 50%). The comparison tool was selected and
reads normalized between samples and Bonferroni correction used
to highlight differences between samples. An alignment indepen-
dent analysis of the date was also undertaken using 5-mers and
frequency landscape distribution (fLAND) analysis [29–31]. The
generation of the 5-mers was performed using a bespoke PERL
script (written by BED; available on request) and PCA analysis was
undertaken in MATLAB on ARCCA, the fLAND analysis was
performed using the software fLAND.
Consistency analysis
Biases in microbiota between the on-tumor and off-tumor
samples across patients were summarized in order to identify taxa
which were either consistently enriched or consistently depleted
in the two niches. All pyrosequencing reads were first mapped to
the SILVA comprehensive database of aligned, quality checked
16S/18S rRNA sequences .300 nt (version SSUParc_100; [32])
using BLAT v34 with default parameters and cutoffs [33]. We
assumed that each read was derived from a different micro-
organism and that the sampling of reads represented the
taxonomic distribution within the intestinal microbiota. For each
sample, every read was assigned to its most similar sequence in
the SILVA database and a summary of the taxonomic
annotations of the detected database sequences was generated.
Each taxonomic clade was assessed to determine whether it
showed a higher fraction of reads in off-tumor or on-tumor
samples for every patient, and a consistency score was calculated
by counting ‘‘+1’’ if the clade was higher off-tumor, ‘‘21’’ if the
clade was higher on-tumor, and ‘‘0’’ if the fraction of reads on-
and off-tumor was identical (e.g. if the clade was not measured in
this patient). Finally, these scores were summed, yielding an
overall consistency score between 26 and +6 that reflects how
consistently the clade was enriched or depleted across all patients.
Note that each sequence in the SILVA database has two taxon-
omic annotations, i.e. EMBL and RDP.
Results
DGGE fingerprinting
As a first exploration, profiles of bacterial 16S rRNA genes were
generated using DGGE for tumor and matching adjacent non-
Table 1. Patient characteristics.
Colon Tumor
Patient Gender Age Stage
1 Localisation
Am6 7 T 2N0M0 sigmoid
Bm6 1 T 2N0M0 rectum/sigmoid
Cm4 9 T 3N1M0 sigmoid
Dm7 1 T 2N0M0 rectum
Em6 7 T 4N0M0 cecum
Ff 6 6 T 2N0M0 rectum
1T, tumor growth into the wall of the intestine; N, spread to nearby lymph
nodes; M, metastases in other organs; numbers 0–4 indicate increasing
severity.
doi:10.1371/journal.pone.0020447.t001
CRC Microbiome
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shown in Figure 1, the microbial communities of tumor tissue and
adjacent ‘‘off-tumor’’ mucosa were strikingly different and similar
results were obtained when RISA fingerprinting was applied to the
same samples (Figure S1). Notably, this result sharply contrasts with the
previous observations that the colonic mucosal microbiota is almost
identical at adjacent sites in healthy subjects [15,16,34–36]. Inspired by
this striking observation, we next aimed for a microbiome sequencing
approach to map the microbiome changes at a high resolution rather
than sequencing of individual distinguishing bands that only represent
the abundant species in a certain sample.
FLX 454 titanium pyrosequencing
To define the colon tumor microbiome at a deep level, we
amplified and sequenced the V1–V3 region of the bacterial 16S
rRNAgenes(TableS1),whichresulted ina totalof193,880 ribotags
of length 401–500 bp. The data showed high coverage values
(.88%) and rarefaction curves indicated satisfactory sampling of
the communities at 90% identity (Figure S2B; Table S2). Libshuff
analysis indicated that all on- and off-tumor communities were
significantly different (p,0.0001) from each other (Table S3).
Importantly, both alignment-dependent and independent methods
supported the observation of these altered tumor microbiomes
(Figure 2, Figure S2C and D; Table S3). Moreover, while DGGE
and RISA only showed minor differences for patient D, subtle, but
significant, differences could be identified by the deep sequencing
approach. This clearly exemplifies the superior resolution that can
be obtained with the latter technology. The data showed a general
tendency of more Bacteroidetes and less Firmicutes from in tumor
tissue compared to matching off-tumor mucosa (Figure S3).
However, as could be expected the observed microbiome shifts
showed a high level of variability among patients (Figure S3A–F)
and in certain cases were even contrary to the general tendency
(Figure S3G). Although S.bovis orC. septicum infectionshave a known
clinical association with CRC, only very few sequences mapped to
rRNA of these two species and no dependable colonization of CRC
tissue was observed. This could be explained by the fact that such
opportunistic pathogens are predominantly present in the transient
adenoma stage of CRC [37].
Consistency analysis
To pinpoint the most imperative microbiome changes during
formation of CRC, consistency across the patients was calculated
for each taxon individually by giving it a score of ‘‘21’’ if the
normalized number of sequence reads of that taxon in the tumor
tissue was higher than in matching off-tumor mucosa, ‘‘+1’’ if the
taxon was more abundant in healthy mucosa and ‘‘0’’ if it was not
detected at all in that patient. Summing these scores across
patients resulted in a consistency score from 26t o+6 for each
taxon (Tables 2 and S4, Figure S4A and B). It should be noted that
some sequences are better annotated by EMBL than by RDP, and
vice versa (see Figure S4C), so we report both rather than
preferentially trusting either of these taxonomic annotations. This
approach showed that CRC tissue was consistently associated with
overrepresentation of the subclass of Coriobacteridae, especially the
genera Slackia and Collinsella, which can be regarded as gut
commensals. On the other hand, members of the Enterobacteriaceae,
such as Citrobacter, Shigella, Cronobacter, Kluyvera, Serratia and
Salmonella spp. (scores between +4 and +6; Table 2; Figure S4A
and B) were underrepresented in CRC tissue. Although these
findings were consistent, the relative abundance of these taxa
differed considerably between on and off tumor mucosa from the
investigated patients as depicted in Figure 3.
Discussion
The most striking observation from our current study was the
dramatically different microbiomes in CRC tissue and adjacent
non-malignant mucosa in 5 of the 6 investigated patients. To our
surprise, however, we found no consistent overrepresentation of
potential pathogenic bacteria in CRC tissue. In contrast,
overrepresented species concerned members of the genera
Coriobacteridae, Roseburia, Fusobacterium and Faecalibacterium, which
are generally regarded as gut commensals with pro-biotic features.
Figure 1. DGGE Fingerprinting of CRC Tissue and Non-malignant Adjacent Mucosa. An internal fragment (,450 bps) of the bacterial 16S
rRNA gene was amplified from colon tissue-extracted DNA by a broad-range PCR approach after which these amplicon mixtures were applied to
DGGE. Patient characteristics can be found in Table 1; off, non-malignant tissue; on, tumor tissue.
doi:10.1371/journal.pone.0020447.g001
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quite dramatic physiological and metabolic alterations that result
from colon carcinogenesis itself [38–40], and that these species
may be regarded as CRC passengers. In fact, recent metabolomics
studies revealed extremely altered nutritional conditions in the
CRC tumor microenvironment compared to non-malignant
Figure 2. Phylogenetic Analysis of Altered Microbiomes. The 454 sequencing data were normalized in MEGAN (Huson et al. 2009) and parsed
through the RDP pyropipeline classifier tool (Cole et al. 2009) to generate a csv file of taxonomic abundance. This file was used as input for MEGAN to
visualize in which families differences between non-malignant tissue (off-tumor) and CRC tissue (on-tumor) communities are present. A high-
resolution image of this Figure for ‘‘zoom-in’’ purposes can be downloaded from Figure S2E.
doi:10.1371/journal.pone.0020447.g002
CRC Microbiome
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concerned a drastic decrease in glucose and pyruvate and an
increase in lactate (low pH), amino acids, lipids and fatty acids.
The intra-patient variability in microbiome alterations could
possibly reflect the intra-individual variability in the CRC tumor
microenvironment [42], resulting in the preferential recruitment of
different classes of intestinal species. Notably, reduced numbers of
Collinsella spp. and Roseburia spp. have previously been found in
elderly subjects using non-steroidal anti-inflammatory drugs
compared to non-users (NSAID [43]; suggesting that these
bacteria need inflammatory niches to optimally colonize the
bowel wall. Interestingly, the genera Roseburia, Fusobacterium and
Faecalibacterium, which are moderately enriched in tumors belong
to the major butyrate producing intestinal bacteria. Butyrate is
thought to be protective against CRC by inducing a p21-
dependent cell cycle arrest resulting in an increased apoptosis
rate of carcinogenic cells [44]. The effects of butyrate are however
still under debate as tumor inhibition may for instance be
restricted to the early phases of carcinogenesis. Markedly, it has
been shown that Faecalibacterium prausnitzii secretes anti-inflamma-
tory factors that block NF-kB activation and IL-8 production in an
experimental animal model for Crohn’s disease [45]. Moreover,
patients with inflammatory bowel disease, who are at increased
risk for CRC, have been associated with lower numbers of F.
prausnitzii in the intestinal population [46]. Finally, Slackia spp. are
known to convert dietary isoflavones into more potent anti-
oxidants [47] capable of inducing apoptotic pathways in tumor
cells [48]. Thus in view of our current data, we could draw the
conclusion that the CRC microenvironment is preferably
colonized by intestinal bacteria with anti-tumorigenic and anti–
carcinogenic properties, which thereby may prevent rapid
progression of this disease. However, one could also argue that
for instance butyrate provides an additional energy source for
tumor cells, while dampening the inflammatory response stops the
Table 2. Consistent CRC-associated Microbiome Shifts
1.
consistency score
Terminal Clade EMBL RDP Bacterial order
Overrepresented in CRC tissue
Slackia . 26 Coriobacteriales
Collinsella . 25 Coriobacteriales
Eubacterium;environmental samples 25. Clostridiales
Coriobacterium;environmental samples 24. Coriobacteriales
Roseburia 24. Clostridiales
Clostridiaceae;environmental samples 24. Coriobacteriales
Fusobacterium 23 23 Fusobacteriales
unclassified_Coriobacteriaceae . 23 Coriobacteriales
unclassified_Peptostreptococcaceae . 23 Clostridiales
Erysipelotrichaceae Incertae Sedis . 23 Erysipelotrichales
Fusobacteria;environmental samples 23. Fusobacteriales
Faecalibacterium;environmental samples 23. Clostridiales
Bacteroidales;environmental samples 23. Bacteroidales
unclassified_Firmicutes - 23 N/A
Underrepresented in CRC tissue
Citrobacter 64Enterobacteriales
Shigella 44Enterobacteriales
Cronobacter 4. Enterobacteriales
Kluyvera 4. Enterobacteriales
Serratia 4. Enterobacteriales
Salmonella enterica subsp. enterica serovar Saintpaul 4 . Enterobacteriales
Eubacteriaceae; environmental samples 4 . Clostridiales
Anaerovorax .4 Clostridiales
unclassified_Ruminococcaceae . 4 Clostridiales
unclassified_Bacteria . 4 N/A
Microbacterium 3. Actinomycetales
Salmonella enterica subsp. enterica serovar Paratyphi B 3 . Enterobacteriales
Clostridium .3 Clostridiales
Peptoniphilus .3 Clostridiales
1only terminal clades with consistency scores ,=23o r.=3 that were found using the EMBL or RDP 16S ribosomal databases as template are shown. Full consistency
data are provided as Table S4 and Figure S4. Both annotations were included because well-annotated sequences by RDP are often not well annotated by EMBLa n dvice
versa (Figure S4C).
doi:10.1371/journal.pone.0020447.t002
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both tumor suppressing or tumor promoting scenarios may be
possible outcomes of the differential colonization of CRC tissue
and further, detailed investigations, will be required to elucidate
this issue.
Another remarkable observation concerned the decreased
presence of members of the Enterobacteriaceae, such as Citrobacter,
Shigella, Cronobacter, Kluyvera, Serratia and Salmonella spp. in tumour
tissue of the investigated CRC patients. This data may suggest that
these bacteria are part of the intrinsic microbiome of CRC
patients, but outcompeted by the above mentioned commensal-
like bacteria upon disease progression. Although we realize that in
the absence of a large reference database of mucosal microbiomes
from healthy individuals it is difficult to draw conclusions on this
observation, we would like to take the opportunity to shortly
review why Enterobacterial intestinal colonization could be
associated with an increased risk for CRC. First, metagenomic
inventories of the human intestinal microbiome showed that
Salmonella, Citrobacter, and Cronobacter were among the low abundant
intestinal species or were even completely absent in healthy
individuals [15,49], which is fully in-line with their pathogenic
character [50]. Contrarily, this bacterial family was detectably
present in non-malignant colonic mucosa samples from CRC
patients [36], while Shen and colleagues recently showed that
Shigella spp displayed an increased abundance in the intrinsic (non-
malignant) microbiome of adenoma patients [51]. Importantly,
the potential of Enterobacteria to initiate CRC has already been
shown for Citrobacter species in an animal model [52], and it is
thought that this increased susceptibility for CRC is caused by an
asymptomatic, but chronic, inflammatory response in the colonic
mucosa [53]. Additionally, several Enterobacterial strains produce
DNA damaging genotoxins [54] and may thereby actively
contribute to the accumulation of mutations that characterize
the adenoma-carcinoma sequence [55]. In this context, our data
may further suggest that upon CRC progression, the tumor
microenvironment changes in such a way that Enterobacteria are
replaced by commensal-like species or bacteria with proposed
probiotic properties that have increased access to and/or can more
efficiently forage in the altered tumor microenvironment. The
disappearance of CRC-driving pathogenic bacteria from advanced
CRC tumor tissue may be analogous to what has been reported
for Helicobacter pylori during gastric cancer progression [56].
Altogether, our study provides an important first glimpse of the
CRC-associated microbiome and indicates a highly dynamic
relationship between intestinal bacteria and developing tumours.
Nonetheless, many open questions need to be addressed in future
studies, including deep microbiome analysis of extended groups of
tumor samples from different disease stages, including adenomas
and biopsies from a large set of non-cancer patients to serve as
reference database. Furthermore, for diagnostic purposes it will be
important to investigate how the local tumour-associated micro-
biome shifts relate to the fecal microbiota composition [57]. A
more detailed analysis of CRC (meta-)genomes and bacterial
transcriptomes is needed to pinpoint the genes that cause
differential colonization in the tumor microenvironment and to
better define high-risk microbial populations. Subsequently, high-
risk and low-risk bacterial populations should be validated in
(animal) models for sporadic CRC, and mechanisms of bacterial
interference in CRC have to be unraveled in more detail. All-in-
all, this sets the agenda for a new exciting era in colorectal cancer
research, integrating microbiology and microbial ecology with
tumor biology. This will lead us towards an increased under-
Figure 3. Consistent Biases in Microbiota CRC Tissue and Non-malignant Adjacent Mucosa. Relative distribution of selected CRC over/
under represented taxa was calculated as the fraction annotated sequences of the total number of reads in that specific sample. Consistency score for
the indicated taxon (see Table 2) is given between brackets and reflects how consistently clades were enriched across patients A–F; green bars
indicate the fraction in off-tumor and red bars indicate fraction of this taxon on-tumor.
doi:10.1371/journal.pone.0020447.g003
CRC Microbiome
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e20447standing of the driving forces of CRC, as well as novel
microbiome-related diagnostic tools and therapeutic interventions.
Supporting Information
Figure S1 RISA fingerprinting of CRC tissue and non-
malignant adjacent mucosa. The intergenic spacer region between
the 16S and 23S rRNA genes was amplified with conserved primer
pairs (Table S1) and analyzed using an Agilent Bioanalyser.
Patient characteristics can be found in Table 1; off, non-malignant
tissue; on, tumor tissue.
(PDF)
Figure S2 A, Read lengths per sample, with Xoff and Xon
coming from off-tumor and on-tumor samples in subject X, the
data was derived from the read lengths post-processing via the
RDP pyropipeline. B, Rarefraction curves for each sample, the
sample key is the same as use for Figure S1. These curves were
generated using MOTHUR, cut off values are shown. C,V e n n
diagram for paired samples generated using MOTHUR, each
diagram shows the OTUs (at 0.03% cut-off) shared and those
unique to each sample from on and off tumor. D, Principle
component analysis of the annotated 16S rRNA sequence data
generated for on and off tumor samples of each patient (A–F),
was plotted as an 0.560.5 interval density distribution. The color
coding shows the natural logarithm of the densities in each
segment. Where there are significant differences (P,0.05)
between tumor tissue and adjacent off-tumor mucosa, a white
cross is shown in that segment. The taxonomic groups
contributing to the most densely populated segments are shown
(and the numbers of sequences contributing are shown in
parentheses).
(PDF)
Figure S3 Taxonomic affiliation of the 16S rRNA gene reads for
each paired sample set from subjects A–F and the combined
samples (G). The figures were generated using MEGAN and show
in which PHYLA (piecharts) and families (barcharts) the main
alterations of levels of reads are found. In the barchart only
families which were greater than 1% of the community are shown.
(PDF)
Figure S4 Consistent biases in microbiota between the on- and
off-tumor samples. The overall consistency scores between +6
(green) and 26 (red) reflects how consistently clades were enriched
across six patients. Trees were visualized with iTOL A, Consistent
clades derived from the EMBL annotation of SILVA sequences. B,
Consistent clades derived from the RDP annotation of SILVA
sequences. C, Differential annotation depth of the SSU rRNA
sequences in the SILVA database by EMBL and RDP. Low
annotation depth means little resolution: many sequences are
either well annotated by RDP (bottom right) or by EMBL (top
left).
(PDF)
Table S1 Primers used in this study.
(PDF)
Table S2 MOTHUR diversity indices of bacterial communities
in samples on- and off-tumor (Xon and Xoff, respectively).
(PDF)
Table S3 Genus level comparison generated with the RDP
library compare tool. Values indicate the number of 16S rRNA
pyrosequencing reads that map to the listed genus. Only
significant differences are shown (P,0.05). A–F: patients; Xoff:
off-tumor tissue; Xon: on-tumor tissue.
(PDF)
Table S4 Consistency scores for CRC associated microbiome
shifts.
(XLS)
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